“Advances in the Pharmacotherapy of Heart Failure: Type 2 Sodium-Glucose Cotransporter Inhibitors (SGLT2) As a Therapeutic Option”. Research, Society and Development 12, no. 3 (March 1, 2023): e12412340502. Accessed January 1, 2026. https://rsdjournal.org/rsd/article/view/40502.